Use and predictors of early cardiac catheterization in high-risk patients with acute coronary syndrome. Analysis from the CRUSADE national registry

被引：0
|
作者：
Saucedo, JF
Bhatt, DL
Li, Y
Roe, MT
Harrington, RA
Berger, PB
Cannon, CP
Gibson, M
Kleiman, N
Brindis, R
Peterson, ED
Gibler, WB
Ohman, EM
机构：
[1] Univ Oklahoma, HSC, Oklahoma City, OK USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Mayo Clin, Rochester, MN USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：71L / 72L
页数：2
相关论文
共 50 条
  • [41] Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry
    E. A. Badings
    R. S. Hermanides
    A. Van Der Sluis
    J. H. E. Dambrink
    A. T. M. Gosselink
    E. Kedhi
    J. P. Ottervanger
    V. Roolvink
    W. S. Remkes
    E. van’t Riet
    H. Suryapranata
    A. W. J. van’t Hof
    Netherlands Heart Journal, 2019, 27 : 73 - 80
  • [42] Utilization and Determinants of In-Hospital Cardiac Catheterization in Patients With Acute Coronary Syndrome From the Middle East
    Panduranga, Prashanth
    Sulaiman, Kadhim
    Al-Zakwani, Ibrahim
    Zubaid, Mohammad
    Rashed, Wafa
    Al-Mahmeed, Wael
    Al-Lawati, Jawad
    Al-Motarreb, Ahmed
    Haitham, Amin
    Suwaidi, Jassim
    Al-Habib, Khalid
    ANGIOLOGY, 2010, 61 (08) : 744 - 750
  • [43] Inpatient management of high-risk acute coronary syndrome patients in a district hospital setting
    A Turley
    M de Belder
    R Smith
    A Shyam-Sundar
    Critical Care, 10 (Suppl 1):
  • [44] Balancing Mortality Benefit vs. Bleeding Risk for Intensive Antiplatelet Therapy among Acute Coronary Syndrome Patients: Insights from the CRUSADE Registry
    Wang, Tracy Y.
    Chen, Anita Y.
    Roe, Matthew T.
    Ohman, Magnus
    Gibler, Brian
    Peterson, Eric D.
    CIRCULATION, 2008, 118 (18) : S916 - S916
  • [45] Better outcome with primary percutaneous coronary intervention in unselected patients with acute coronary syndrome. A report from the AMIS Plus Registry
    Erne, P.
    Radovanovic, D.
    Eberli, F. R.
    Urban, P.
    Stauffer, J. C.
    Rickli, H.
    Bertel, O.
    Windecker, S.
    EUROPEAN HEART JOURNAL, 2007, 28 : 508 - 508
  • [46] Bleeding risk in patients with acute coronary syndrome in a Turkish population: Results from the Turkish Acute Coronary Syndrome Registry (TACSER) study
    Avci, Eyup
    Kiris, Tuncay
    Akgun, Didar Elif
    Celik, Aykan
    Akcay, Filiz Akyildiz
    Acar, Burak
    Kurmus, Ozge
    Altindag, Rojuva
    Safak, Ozgen
    Demirtas, Abdullah Orhan
    Guzel, Tuncay
    Ozturk, Onder
    Yildirim, Tarik
    Yuksek, Umit
    Ergene, Asim Oktay
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (11)
  • [47] The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes: insight from the Diabetes and Acute Coronary Syndrome Registry
    Ferlini, Marco
    Musumeci, Giuseppe
    Grieco, Niccolo
    Rossini, Roberta
    De Servi, Stefano
    Mafrici, Antonio
    Sponzilli, Carlo
    Demarchi, Andrea
    Assanelli, Emilio M.
    Camisasca, Paola
    Chizzola, Giuliano
    Corrada, Elena
    Farina, Andrea
    Pedrinazzi, Claudio
    Lettieri, Corrado
    Visconti, Luigi Oltrona
    CORONARY ARTERY DISEASE, 2018, 29 (04) : 309 - 315
  • [48] Management and clinical consequences of major bleeding in high-risk patients following an acute coronary syndrome. Is aspirin the problem? Insights from the APPRAISE-2 trial
    Hagstrom, E.
    Wojdyla, D.
    Neely, M. L.
    Stevens, S. R.
    Harrington, R. A.
    Wallentin, L.
    Alexander, J. H.
    Goodman, S. G.
    Lopes, R. D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 861 - 862
  • [49] Impact of comorbidities and gender on the use of coronary interventions in patients with high-risk non-ST-segment elevation acute coronary syndrome
    Worrall-Carter, Linda
    McEvedy, Samantha
    Wilson, Andrew
    Rahman, Muhammad Aziz
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (04) : E128 - E136
  • [50] Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome.
    Lee, ST
    Hahn, JS
    Ko, YW
    Min, YH
    BLOOD, 2001, 98 (11) : 215B - 215B
12345